To make chemotherapy dosing more accurate, MIT engineers have come up with an alternative approach that can enable the dose to be personalized to the patient. Their system measures how much drug ...

Immutep Ltd (ASX:IMM) has dosed the first patient of its Phase 3 TACTI-004 non-small cell lung cancer trial – the final stage ...

That’s why cancer-fighting drugs placed into this space are called intrathecal chemotherapy, or IT chemo. Intrathecal chemo is used most often to treat cancers that involve the brain or spinal ...

Significant contributions have been made by technological improvements in radiotherapy, as well as by the introduction of novel chemotherapy agents and dosing schedules. This article will review ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

announces the dosing of the first patient in its Phase 2b clinical trial, referred to as HALT-CINP (Halneuron ® Treatment of Chemotherapy-Induced Neuropathic Pain), evaluating Halneuron ® for ...

Approval was based on improved survival outcomes vs platinum-based chemotherapy as demonstrated in the phase 3 NIAGARA study.

In animal models of chemotherapy-induced neuropathy ... and exerts long-lasting effects that persist for days after the end of dosing, suggesting a disease-modifying capability.

(MENAFN- GlobeNewsWire - Nasdaq) Opioid-free and addiction-free pain treatment therapy could address $1.5B worldwide CINP market “Our goal is to recruit 100 patients with CINP by the fourth ...